Union européenne -
français -
EMA (European Medicines Agency)
tybost
gilead sciences ireland uc - cobicistat - infections au vih - antiviraux à usage systémique - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
tybost 150 mg comprimés pelliculés
gilead sciences switzerland sàrl - cobicistatum - comprimés pelliculés - cobicistatum 150 mg, silice colloidalis anhydrica, cellulosum microcristallinum, carmellosum natricum seulement tenus ensemble, magnésium stearas, Überzug: poly(alcool vinylicus), macrogolum 3350, talc, e 110 0,32 mg, e 171, e 172 (jaune), pour compresso haze corresp. sodium 2,1 mg. - les infections à vih - synthetika
Canada -
français -
Health Canada
tybost comprimé
gilead sciences canada inc - cobicistat - comprimé - 150mg - cobicistat 150mg - other miscellaneous therapeutic agents